Dr. Brian T. Hill
Claim this profileCleveland Clinic Foundation
Area of expertise
Chronic Lymphocytic Leukemia
Brian T. Hill has run 5 trials for Chronic Lymphocytic Leukemia. Some of their research focus areas include:
Lymphoma
Brian T. Hill has run 5 trials for Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Cleveland Clinic Foundation
The Cleveland Clinic Foundation
Clinical Trials Brian T. Hill is currently running
GM T Cell Therapy Long-Term Follow-Up
for Cancer
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one infusion of GM T cells will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.
Recruiting
1 award
Phase 2 & 3
Venetoclax + Obinutuzumab
for Leukemia
This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with the venetoclax and obinutuzumab early (before patients have symptoms) may have better outcomes for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma compared to starting treatment with the venetoclax and obinutuzumab after patients show symptoms.
Recruiting
2 awards
Phase 3
1 criteria
More about Brian T. Hill
Clinical Trial Related
7 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Brian T. Hill has experience with
- Venetoclax
- Obinutuzumab
- NKX019
- Fludarabine
- Cyclophosphamide
- JCAR017
Breakdown of trials Brian T. Hill has run
Chronic Lymphocytic Leukemia
Lymphoma
Mixed-Cell Lymphoma
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian T. Hill specialize in?
Brian T. Hill focuses on Chronic Lymphocytic Leukemia and Lymphoma. In particular, much of their work with Chronic Lymphocytic Leukemia has involved CD19 positive patients, or patients who are CD20 positive.
Is Brian T. Hill currently recruiting for clinical trials?
Yes, Brian T. Hill is currently recruiting for 2 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Brian T. Hill has studied deeply?
Yes, Brian T. Hill has studied treatments such as Venetoclax, Obinutuzumab, NKX019.
What is the best way to schedule an appointment with Brian T. Hill?
Apply for one of the trials that Brian T. Hill is conducting.
What is the office address of Brian T. Hill?
The office of Brian T. Hill is located at: Cleveland Clinic Foundation, Cleveland, Ohio 44195 United States. This is the address for their practice at the Cleveland Clinic Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.